Is ethnicity associated with morphine's side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomy

Paediatric Anaesthesia

Volumn 22, Issue 7, 2012, Pages 669-675

  Jimenez, Nathalia ^a   Anderson, Gail D ^a   Shen, Danny D ^a   Nielsen, Susan S ^b   Farin, Federico M ^a   Seidel, Kristy ^c   Lynn, Anne M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

acute pain; opioids; pharmacokinetics

Indexed keywords

MORPHINE;

ADOLESCENT; ADVERSE OUTCOME; ANALGESIA; ARTICLE; CAUCASIAN; CHILD; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RACE DIFFERENCE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TONSILLECTOMY; TREATMENT RESPONSE; VOMITING;

ADENOIDECTOMY; ADOLESCENT; ANALGESICS, OPIOID; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENZYMES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HISPANIC AMERICANS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MORPHINE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PRURITUS; RECEPTORS, OPIOID; TONSILLECTOMY; TREATMENT OUTCOME; VOMITING;

EID: 84861818243     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2012.03844.x     Document Type: Article

References (24)

1. Cepeda MS, Farrar JT, Roa JH, et al. Ethnicity influences morphine pharmacokinetics and pharmacodynamics. Clin Pharmacol 2001; 70: 351-361.
2. Zhou HH, Sheller JR, Nu H, et al. Ethnic differences in response to morphine. Clin Pharmacol Ther 1993; 54: 507-513.
3. Todd KH, Samaroo N, Hoffman JR,. Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA 1993; 269: 1537-1539.
4. Tamayo-Sarver JH, Hinze SW, Cydulka RK, et al. Racial and ethnic disparities in emergency department analgesic prescription. Am J Public Health 2003; 93: 2067-2073.
5. Sawyer MB, Innocenti F, Das Scheng C, et al. A pharmacogenetic study of uridine diphosphate-glucuronyltransferase 2B7 in patients receiving morphine. Clin Pharmacol Ther 2003; 73: 566-574.
6. Duguay Y, Baar C, Skorpen F, et al. A novel functional polymorphism in the uridine diphosphate glusuronosyltransferase 2B7 promoter with significant impact on promoter activity. Clin Pharmacol Ther 2004; 75: 223-233.
7. Fujita K, Ando Y, Yamamoto W, et al. Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer. Cancer Chemother Pharmacol 2010; 65: 251-258.
8. Araki K, Fujita K, Ando Y, et al. Pharmacogenetic impact of polymorphisms in the coding region of UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer. Cancer Sci 2006; 97: 1255-1259.
9. Klepstad P, Dale O, Skorpen F, et al. Genetic variability and clinical efficacy of morphine. Acta Anesthesiol Scand 2005; 49: 902-908.
10. Sia AT, Lim Y, Lim EC, et al. A118G single nucleotide polymorphisms of human μ-Opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 2008; 109: 520-526.
11. Coulbault L, Beaussier M, Verstuyft C, et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther 2006; 79: 316-324.
12. Rakvag TT, Ross JR, Sato H, et al. Genetic variation in the catechol-o-methyltransferase gene and morphine requirements in cancer patients with pain. Mol Pain 2008; 18: 64.
13. Campa D, Gioia A, Tomei A, et al. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relieve. Clin Pharmacol Ther 2008; 83: 559-566.
14. Ross JR, Rutter D, Welsh K, et al. Clinical response to morphine in cancer patients and genetic variation in candidate genes. Pharmacogenomics 2005; 5: 324-336.
15. Mogil JS, Ritchie J, Smith SB, et al. Melanocortin-1 receptor gene variants affect pain and μ-opioid analgesia in mice and humans. J Med Genet 2005; 42: 583-587.
16. Tan EC, Lim EC, Teo YY, et al. Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 2009; 23: 32.
17. Strauss SG, Lynn AM, Bratton SL, et al. Ventilatory response to CO2 in children with obstructive sleep apnea from adenotonsillar hypertrophy. Anesth Analg 1999; 89: 328-332.
18. Lynn AM, Nespeca MK, Bratton SL, et al. Intravenous morphine in postoperative infants: intermittent bolus dosing versus targeted continuous infusions. Pain 2000; 88: 89-95.
19. McRorrie TI, Lynn AM, Nespeca MK, et al. The maturation of morphine clearance and metabolism. Am J Dis Child 1992; 146: 972-976.
20. Merkel SI, Voepel-Lewis T, Shayevitz JR, et al. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 1997; 23: 293-297.
21. Galinkin JL, Fazi LM, Cuy RM, et al. Use of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesia. Anesthesiology 2000; 93: 1378-1383.
22. Fernandez A, Schillinger D, Grumbach K, et al. Physician language ability and cultural competence. An exploratory study of communication with Spanish-speaking patients. J Gen Intern Med 2004; 19: 167-174.
23. Romberg RR, Olofsen E, Biji H, et al. Polymorphisms of μ-Opioid receptor gene (OPRM1:c:118A>G) does not protect against opioid induced respiratory depression despite reduced analgesic response. Anesthesiology 2005; 102: 522-530.
24. Osborne R, Joel S, Grebenik K, et al. The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clin Pharmacol Ther 1993; 54: 158-167.